Asymmetric hetero [4] arene as well as preparation method and application thereof
Asymmetric hetero[4]aromatic hydrocarbons were synthesized by one pot method and formed eutectic materials with 1,2,4,5-tetracyanobenzene, which solved the problem of a single structure of existing macrocyclic aromatic hydrocarbons and achieved simple operation and high conversion The preparation of novel macrocyclic compounds and eutectic materials has expanded its application in supramolecular chemistry.
Patent Information
- Application Number
- CN202410952597.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-08
AI Technical Summary
The existing macrocyclic aromatic hydrocarbons have a single structure, which limits their application in supramolecular chemistry and lacks new heteroaromatic hydrocarbons with different structural units.
Asymmetric hetero[4]aromatic hydrocarbons were synthesized by one pot method, and thermal reaction was carried out using 2,6-diethoxynaphthalene, 1,3-dimethoxybenzene and paraformaldehyde under trifluoroacetic acid catalyzed, and passed through the column Purification by chromatography, asymmetric hetero[4]aromatic hydrocarbons with novel structure were prepared, and mixed with 1,2,4,5-tetracyanobenzene in dichloromethane to form eutectic material.
The preparation of new macrocyclic compounds with simple operation, low equipment requirements and high conversion rate has been realized, new members have been added to the macrocyclic compound family, and its application prospects have been expanded through the preparation of eutectic materials.
Smart Images

Figure CN118908813A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of supramolecular chemistry, and more specifically to an asymmetric hetero[4]arene and a preparation method and application thereof. Background Art
[0002] Since the discovery of crown ethers by C.J. Pedersen of DuPont in the United States in the 1960s, more and more macrocyclic compounds have been synthesized and have become the main research object of supramolecular chemistry. Among them, macrocyclic aromatic hydrocarbons (e.g., calixarene, columnar aromatic hydrocarbons, biphenyl aromatic hydrocarbons, and prismatic aromatic hydrocarbons) have attracted widespread attention due to their special structures and excellent host-guest chemical properties. However, most of the current macrocyclic aromatic hydrocarbons are composed of the same structural units, which limits their further application. Heteroaromatic hydrocarbons are macrocyclic aromatic hydrocarbons composed of different structural units. Their diverse structural units provide many reaction sites for the synthesis of heteroaromatic hydrocarbons, thereby obtaining heteroaromatic hydrocarbons with different structures, shapes, and properties, which enable heteroaromatic hydrocarbons to have a wider range of applications. Therefore, the design and synthesis of new heteroaromatic hydrocarbons with different structural units is of great significance to supramolecular chemistry.
[0003] The patent with publication number CN117534547A discloses a method for synthesizing a hetero[3]aromatic macrocyclic compound, which has the advantages of simple operation, mild reaction conditions, and low raw material cost. In addition, the macrocyclic compound also has the ability to efficiently capture iodine. Therefore, the hetero[3]aromatic macrocyclic compound has certain industrial value. The patent with publication number CN116621681A discloses a method for synthesizing a hetero[4]aromatic macrocyclic compound, in which 2,6-diethoxynaphthalene, 1,3-dimethoxybenzene and polyformaldehyde are reacted under the catalysis of trifluoroacetic acid, and then the final product is separated by column chromatography. The synthesis method has mild reaction conditions, rapid reaction, high conversion rate, and has potential application prospects in the purification of petrochemical raw materials. The above research provides guidance for the synthesis of the compounds in the present invention. Summary of the invention
[0004] The purpose of the present invention is to overcome the above-mentioned defects of the prior art, provide an asymmetric hetero[4]arene and a preparation method and application thereof, and successfully design and synthesize a new type of macrocyclic compound, namely, asymmetric hetero[4]arene, by a one-pot method. The process operation is simple, the equipment requirements are low, the conversion rate is high, and a new member is added to the macrocyclic compound family; and based on the electron-rich characteristics of the macrocyclic compound, it is mixed with the electron-deficient acceptor 1,2,4,5-tetracyanobenzene in a molar ratio of 1:1 in dichloromethane to successfully prepare a eutectic material based on asymmetric hetero[4]arene.
[0005] To achieve the above object, the technical solution of the present invention is as follows:
[0006] An asymmetric hetero[4]arene, the structure of the asymmetric hetero[4]arene is shown below:
[0007]
[0008] The present invention also discloses a method for preparing the above-mentioned asymmetric hetero[4]arene, comprising the following steps:
[0009] (1) adding 2,6-diethoxynaphthalene, 1,3-dimethoxybenzene, paraformaldehyde and a catalyst trifluoroacetic acid into an organic solvent for thermal reaction, and monitoring the reaction by thin layer chromatography. After the reaction is completed, the reaction is quenched by neutralizing the trifluoroacetic acid, and the organic layer solution is obtained by liquid separation;
[0010] (2) Purifying the organic layer solution by column chromatography and activating it to obtain an asymmetric hetero[4]arene.
[0011] Optionally, in the step (1), the equivalent ratio of the 2,6-diethoxynaphthalene, the 1,3-dimethoxybenzene, and the polyformaldehyde is (0.9-1.1):(2.9-3.1):(2-3).
[0012] Optionally, in step (1), the temperature of the thermal reaction is 60°C to 65°C; and the time of the thermal reaction is 28min to 32min.
[0013] Optionally, in step (1), the organic solvent is a chloroform solution; and trifluoroacetic acid is neutralized with a saturated aqueous sodium carbonate solution.
[0014] Optionally, in step (2), the activation temperature is 120°C to 150°C; and the activation time is 6h to 9h.
[0015] Optionally, in step (2), the column chromatography eluent includes one of petroleum ether and dichloromethane.
[0016] The present invention also discloses the use of the above-mentioned asymmetric hetero[4]arene in the preparation of a eutectic material, wherein the asymmetric hetero[4]arene is used as an electron donor and 1,2,4,5-tetracyanobenzene is used as an electron acceptor, and the electron donor and the electron acceptor are mixed in a molar ratio of 1:1 in dichloromethane to obtain a eutectic material based on the hetero[4]arene.
[0017] Optional, including:
[0018] (1) mixing hetero[4]arene and 1,2,4,5-tetracyanobenzene in a molar ratio of 1:1, and adding dichloromethane dropwise until the powder is completely dissolved to obtain a mixed solution;
[0019] (2) The mixed solution is stored at 0° C. overnight, the precipitated crystals are collected by filtration and activated to obtain the asymmetric hetero[4]arene-based co-crystal material.
[0020] Optionally, in step (2), the activation temperature is 120°C to 150°C; and the activation time is 6h to 9h.
[0021] Implementing the embodiments of the present invention will have the following beneficial effects:
[0022] The present invention successfully prepares a novel asymmetric hetero[4]arene by a one-pot method. Compared with the prior art, the process is simple to operate, has low equipment requirements, high conversion rate, and adds a new member to the macrocyclic compound family. In addition, the macrocyclic compound can also be used to prepare eutectic materials. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 1 is the H NMR spectrum of the asymmetric hetero[4]arene obtained in Example 1 of the present invention.
[0024] Figure 2 5 is the mass spectrum of the asymmetric hetero[4]arene obtained in Example 1 of the present invention.
[0025] Figure 3 3 is the thermogravimetric curve of the asymmetric hetero[4]arene obtained in Example 1 of the present invention.
[0026] Figure 4 1 is the powder X-ray diffraction spectrum of the asymmetric hetero[4]arene obtained in Example 1 of the present invention.
[0027] Figure 5 (a) Top view, (b) side view of the single crystal structure of the asymmetric hetero[4]arene obtained in Example 1 of the present invention.
[0028] Figure 6 This is the H NMR spectrum of 1,2,4,5-tetracyanobenzene in Example 2 of the present invention.
[0029] Figure 7 This is the H NMR spectrum of the asymmetric hetero[4]arene and 1,2,4,5-tetracyanobenzene in Example 2 of the present invention after forming a cocrystal.
[0030] Figure 8 This is a H-NMR stacking diagram of the asymmetric hetero[4]arene, 1,2,4,5-tetracyanobenzene, and their cocrystals in Example 2 of the present invention.
[0031] Fig. 9 The UV-visible absorption spectra of the asymmetric hetero[4]arene, 1,2,4,5-tetracyanobenzene, and their cocrystals in Example 2 of the present invention are shown.
[0032] Fig.10 The figure is the powder X-ray diffraction spectrum of the asymmetric hetero[4]arene, 1,2,4,5-tetracyanobenzene, and their cocrystals in Example 2 of the present invention. DETAILED DESCRIPTION
[0033] The present invention is further described below in conjunction with specific embodiments, but the present invention is not limited in any way.
[0034] The present invention discloses an asymmetric hetero[4]arene, and the structure of the asymmetric hetero[4]arene is shown below:
[0035]
[0036] The present invention also discloses a method for preparing the above-mentioned asymmetric hetero[4]arene, comprising the following steps:
[0037] (1) 2,6-diethoxynaphthalene, 1,3-dimethoxybenzene, polyformaldehyde and a catalyst trifluoroacetic acid are added to an organic solvent for thermal reaction, and the reaction is monitored by thin layer chromatography. After the reaction is completed, the reaction is quenched by neutralizing the trifluoroacetic acid, and the organic layer solution is obtained by separation.
[0038] (2) The organic layer solution is purified by column chromatography and activated to obtain asymmetric hetero[4]arene.
[0039] In a specific embodiment, in step (1), the equivalent ratio of 2,6-diethoxynaphthalene, 1,3-dimethoxybenzene, and paraformaldehyde is (0.9-1.1):(2.9-3.1):(2-3).
[0040] In a specific embodiment, in step (1), the temperature of the thermal reaction is 60° C. to 65° C.; and the time of the thermal reaction is 28 min to 32 min.
[0041] In one specific embodiment, in step (1), the organic solvent is a chloroform solution; and the trifluoroacetic acid is neutralized with a saturated sodium carbonate aqueous solution.
[0042] In a specific embodiment, in step (2), the activation temperature is 120° C. to 150° C., and the activation time is 6 h to 9 h.
[0043] In a specific embodiment, in step (2), the column chromatography eluent comprises one of petroleum ether and dichloromethane.
[0044] The present invention also discloses the use of the above-mentioned asymmetric hetero[4]arene in the preparation of a eutectic material, wherein the asymmetric hetero[4]arene is used as an electron donor and 1,2,4,5-tetracyanobenzene is used as an electron acceptor, and the electron donor and the electron acceptor are mixed in a molar ratio of 1:1 in dichloromethane to obtain a eutectic material based on the hetero[4]arene.
[0045] In a specific embodiment, it specifically includes:
[0046] (1) Hetero[4]arene and 1,2,4,5-tetracyanobenzene are mixed at a molar ratio of 1:1, and dichloromethane is added dropwise until all the powders are dissolved to obtain a mixed solution.
[0047] (2) The mixed solution was stored at 0° C. overnight, and the precipitated crystals were collected by filtration and activated to obtain a co-crystal material based on asymmetric hetero[4]arene.
[0048] In a specific embodiment, in step (2), the activation temperature is 120° C. to 150° C., and the activation time is 6 h to 9 h.
[0049] The following are specific embodiments
[0050] Example 1
[0051] Preparation of unsymmetrical hetero[4]arenes:
[0052]
[0053] 4 g of 2,6-dimethoxynaphthalene, 2 g of 1,3-dimethoxybenzene and 1.2 g of paraformaldehyde were dissolved in 400 ml of chloroform, and 20 ml of trifluoroacetic acid was added to catalyze the reaction while stirring at room temperature, and then heated to 60° C. and stirred. After the reaction was complete and cooled to room temperature, 50 ml of saturated sodium bicarbonate aqueous solution was added to quench the reaction, and after separation, the asymmetric hetero[4]arene was obtained by column chromatography, which was denoted as H, and the eluent was petroleum ether or dichloromethane. The yield of the asymmetric hetero[4]arene product in this example was 30%.
[0054] like Figure 1-5 As shown, the characterization data of the asymmetric hetero[4]arene prepared in this example are as follows:
[0055] H 1 H NMR (600MHz, CDCl3, 293K) (ppm): 7.44 (d, J=12Hz, 2H), 7.00 (d,
[0056] J=12Hz,2H),6.52(s,2H),6.46(s,1H),6.23(s,1H),6.56(s,1H),4.48(d,J=24Hz,2H),4.08(d,J=24Hz,2H),3.99( s,6H),3.97-3.94(m,4H),3.89(s,6H),3.68(d,J=24Hz,2H),3.55(s,6H),3.36(d,J=24Hz,2H),1.27(t,J=9Hz,6H).
[0057] High-resolution mass spectrometry test value m / z: 701.3085, corresponding to [asymmetric hetero[4]arene + Na] + .
[0058] Melting range: 263℃~264℃.
[0059] Powder X-ray diffraction patterns showed that the obtained asymmetric hetero[4]arene had good crystallinity.
[0060] Thermogravimetric curves showed that the obtained asymmetric hetero[4]arene had good thermal stability.
[0061] The single crystal structure and related parameters show that the obtained asymmetric hetero[4]arene has a good crystal structure.
[0062] Example 2
[0063] Preparation of co-crystal materials based on asymmetric hetero[4]arene:
[0064] 2 g of asymmetric hetero[4]arene and 0.5 g of 1,2,4,5-tetracyanobenzene (TCNB) were weighed and placed in 20 mL of dichloromethane until they were completely dissolved. At this time, the solution was dark purple. The solution was stored at 0°C overnight, and the precipitated crystals were collected by filtration. The obtained crystals were activated at 120°C for 6 h to obtain a light purple powder, which was the cocrystal material of the asymmetric hetero[4]arene, recorded as H-TCNB.
[0065] like Figure 6-10 As shown, the characterization data of the eutectic material prepared in this embodiment are as follows:
[0066] TCNB 1 H NMR (600MHz, CDCl3, 293K) (ppm): 8.26 (s, 1H).
[0067] H-TCNB 1 H NMR (600MHz, CDCl3, 293K) (ppm): 8.13 (s, 1H), 7.44 (d, J=
[0068] 12Hz,2H),7.00(d,J=12Hz,2H),6.52(s,2H),6.46(s,1H),6.23(s,1H),6.56(s,1H),4.48(d,J=24Hz,2H),4.08(d,J=24Hz,2 H),3.99(s,6H),3.97-3.94(m,4H),3.89(s,6H),3.68(d,J=24Hz,2H),3.55(s,6H),3.36(d,J=24Hz,2H),1.27(t,J=9Hz,6H).
[0069] The obtained co-crystal materials based on asymmetric hetero[4]arene 1 The H NMR stacking diagram revealed that the characteristic peak of 1,2,4,5-tetracyanobenzene in the eutectic material shifted 0.13 ppm to a higher field compared with that of pure 1,2,4,5-tetracyanobenzene, proving that the asymmetric hetero[4]arene and 1,2,4,5-tetracyanobenzene were complexed.
[0070] The UV-visible absorption spectrum of the obtained co-crystal material based on asymmetric hetero[4]arene revealed that the co-crystal material had a charge transfer absorption band at around 425nm, proving that the asymmetric hetero[4]arene and 1,2,4,5-tetracyanobenzene were complexed.
[0071] The powder X-ray diffraction spectrum of the obtained cocrystal material based on asymmetric hetero[4]arene showed that the spectrum of the cocrystal material changed significantly compared with the spectrum of asymmetric hetero[4]arene and 1,2,4,5-tetracyanobenzene, proving that the crystal form of asymmetric hetero[4]arene and 1,2,4,5-tetracyanobenzene changed after complexation.
[0072] In summary, the present invention successfully designed and synthesized a new type of macrocyclic compound, namely asymmetric hetero[4]arene, by using a one-pot method. Compared with the prior art, the process is simple to operate, has low equipment requirements, high conversion rate, and adds a new member to the macrocyclic compound family. Based on the electron-rich properties of the macrocyclic compound, it was mixed with the electron-deficient acceptor 1,2,4,5-tetracyanobenzene in a molar ratio of 1:1 in dichloromethane to prepare a eutectic material based on asymmetric hetero[4]arene.
[0073] The above-mentioned embodiments only express several implementation methods of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the patent application. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. An asymmetric hetero[4]arene, characterized in that The structure of the asymmetric hetero[4]arene is shown below:
2. A method for preparing an asymmetric hetero[4]arene as claimed in claim 1, characterized in that: The following steps are involved: (1) adding 2,6-diethoxynaphthalene, 1,3-dimethoxybenzene, paraformaldehyde and a catalyst trifluoroacetic acid into an organic solvent for thermal reaction, and monitoring the reaction by thin layer chromatography. After the reaction is completed, the reaction is quenched by neutralizing the trifluoroacetic acid, and the organic layer solution is obtained by liquid separation; (2) Purifying the organic layer solution by column chromatography and activating it to obtain an asymmetric hetero[4]arene.
3. The preparation method according to claim 2, characterized in that: In the step (1), the equivalent ratio of the 2,6-diethoxynaphthalene, the 1,3-dimethoxybenzene, and the paraformaldehyde is (0.9-1.1):(2.9-3.1):(2-3).
4. The preparation method according to claim 2, characterized in that: In the step (1), the temperature of the thermal reaction is 60° C. to 65° C.; and the time of the thermal reaction is 28 min to 32 min.
5. The preparation method according to claim 2, characterized in that: In step (1), the organic solvent is a chloroform solution; and trifluoroacetic acid is neutralized with a saturated sodium carbonate aqueous solution.
6. The preparation method according to claim 2, characterized in that: In the step (2), the activation temperature is 120° C. to 150° C.; and the activation time is 6 h to 9 h.
7. The preparation method according to claim 2, characterized in that: In the step (2), the column chromatography eluent includes one of petroleum ether and dichloromethane.
8. Use of the asymmetric hetero[4]arene according to claim 1 in preparing a eutectic material, characterized in that: Using an unsymmetrical hetero[4]arene as an electron donor and 1,2,4,5-tetracyanobenzene as an electron acceptor, the electron donor and the electron acceptor are mixed in a molar ratio of 1:1 in dichloromethane to obtain a cocrystal material based on hetero[4]arene.
9. The use according to claim 9, characterized in that: Specifically include: (1) mixing hetero[4]arene and 1,2,4,5-tetracyanobenzene in a molar ratio of 1:1, and adding dichloromethane dropwise until the powder is completely dissolved to obtain a mixed solution; (2) The mixed solution is stored at 0° C. overnight, the precipitated crystals are collected by filtration and activated to obtain the asymmetric hetero[4]arene-based co-crystal material.
10. The use according to claim 9, characterized in that: In step (2), the activation temperature is 120° C. to 150° C.; and the activation time is 6 h to 9 h.
Citation Information
Patent Citations
Synthetic method of iminodibenzyl derivative macrocyclic compound
CN116554178A
Eutectic material based on hetero [4] arene as well as preparation method and application of eutectic material
CN116606196A
Mixed [3] arene macrocyclic compound as well as preparation method and application thereof
CN117534547A
MACROCYCLIC AND CAGE-LIKE MOLECULE BASED ON BIPHEN[n]ARENE AND DERIVATIVE, SYNTHESIS METHOD AND USE THEREOF
US20230192692A1
